Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Parikh

Showing results (341-350 of 385) with videos related to

Pageof 39
Sort By:
ESC Heart Failure|February 19, 2026
Clinical risk prediction models for worsening heart failure events and all-cause mortality in adults with mild-to-moderate chronic kidney diseaseSoham Patel, Kaiwen Sun, Alan S Go, et al.
Translational Psychiatry|October 10, 2019
Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressantsChelsey Ju, Laura M Fiori, Raoul Belzeaux, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|June 17, 2022
Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive DisorderSmadar V Tourjman, Gabriella Buck, Didier Jutras-Aswad, et al.
Translational Psychiatry|October 12, 2024
Modulation of neural oscillations in escitalopram treatment: a Canadian biomarker integration network in depression studyBenjamin Schwartzmann, Raaj Chatterjee, Yasaman Vaghei, et al.
Scientific Reports|September 15, 2023
A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring StudyAnastasiya Slyepchenko, Rudolf Uher, Keith Ho, et al.
American Journal of Nephrology|November 24, 2022
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 StudiesCarla Nester, Gerald B Appel, Andrew S Bomback, et al.
American Heart Journal|June 20, 2025
Electronically delivered, cardiovascular-focused messaging to improve influenza vaccination: Rationale, design, and baseline characteristics of the Kaiser Permanente VACCination Improvement with Nudge-based CardiovAscular Targeted Engagement (KP-VACCINATE) MegatrialAnkeet S Bhatt, Alan S Go, Rishi V Parikh, et al.
Journal of Affective Disorders|December 24, 2023
Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depressionSagar V Parikh, Jennifer L Vande Voort, Anastasia K Yocum, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 30, 2020
Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) ReportKatharine Dunlop, Sakina J Rizvi, Sidney H Kennedy, et al.
NEJM Evidence|August 30, 2025
Cardiovascular-Focused Messaging to Improve Influenza Vaccination RatesAnkeet S Bhatt, Natalia C Berry, Rishi V Parikh, et al.
Pageof 39

Showing results (341-350 of 385) with videos related to

Sort By:
Pageof 39
ESC Heart Failure|February 19, 2026
Clinical risk prediction models for worsening heart failure events and all-cause mortality in adults with mild-to-moderate chronic kidney diseaseSoham Patel, Kaiwen Sun, Alan S Go, et al.
Translational Psychiatry|October 10, 2019
Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressantsChelsey Ju, Laura M Fiori, Raoul Belzeaux, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|June 17, 2022
Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive DisorderSmadar V Tourjman, Gabriella Buck, Didier Jutras-Aswad, et al.
Translational Psychiatry|October 12, 2024
Modulation of neural oscillations in escitalopram treatment: a Canadian biomarker integration network in depression studyBenjamin Schwartzmann, Raaj Chatterjee, Yasaman Vaghei, et al.
Scientific Reports|September 15, 2023
A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring StudyAnastasiya Slyepchenko, Rudolf Uher, Keith Ho, et al.
American Journal of Nephrology|November 24, 2022
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 StudiesCarla Nester, Gerald B Appel, Andrew S Bomback, et al.
American Heart Journal|June 20, 2025
Electronically delivered, cardiovascular-focused messaging to improve influenza vaccination: Rationale, design, and baseline characteristics of the Kaiser Permanente VACCination Improvement with Nudge-based CardiovAscular Targeted Engagement (KP-VACCINATE) MegatrialAnkeet S Bhatt, Alan S Go, Rishi V Parikh, et al.
Journal of Affective Disorders|December 24, 2023
Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depressionSagar V Parikh, Jennifer L Vande Voort, Anastasia K Yocum, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 30, 2020
Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) ReportKatharine Dunlop, Sakina J Rizvi, Sidney H Kennedy, et al.
NEJM Evidence|August 30, 2025
Cardiovascular-Focused Messaging to Improve Influenza Vaccination RatesAnkeet S Bhatt, Natalia C Berry, Rishi V Parikh, et al.
Pageof 39